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Summary
Successful treatment of human tuberculosis requires
6–9 months’ therapy with multiple antibiotics. Incom-
plete clearance of tubercle bacilli frequently results
in disease relapse, presumably as a result of reacti-
vation of persistent drug-tolerant Mycobacterium
tuberculosis cells, although the nature and location
of these persisters are not known. In other patho-
gens, antibiotic tolerance is often associated with
the formation of bioﬁlms – organized communities of
surface-attached cells – but physiologically and
genetically deﬁned M. tuberculosis bioﬁlms have not
been described. Here, we show that M. tuberculosis
forms bioﬁlms with speciﬁc environmental and
genetic requirements distinct from those for plank-
tonic growth, which contain an extracellular matrix
rich in free mycolic acids, and harbour an important
drug-tolerant population that persist despite expo-
sure to high levels of antibiotics.
Introduction
Human tuberculosis infections typically require treatment
with multiple antibiotics for 6–9 months to avoid
re-emergence of the disease (Hopewell et al., 2006). The
reasons why such extended treatments are required are
not completely understood, but as antibiotics effectively
kill Mycobacterium tuberculosis during the ﬁrst 14 days of
treatment (Jindani et al., 2003; Sirgel et al., 2005), a sub-
population of drug-tolerant cells that are either inacces-
sible or non-responsive to small molecules must persist
(Wallis et al., 1999). Current models of M. tuberculosis
persistence typically invoke the presence of dormant
populations of non-growing cells that reactivate upon host
immunosuppression (Wayne and Sohaskey, 2001). While
in vitro data indicate that active growth is important for
susceptibility of M. tuberculosis to many front-line antibi-
otics (Xie et al., 2005), mutant strains that are defective in
in vitro dormancy do not appear defective in in vivo per-
sistence (Parish et al., 2003; Voskuil et al., 2003; Rustad
et al., 2008).
In other infectious diseases, such as Pseudomonas
aeruginosa in cystic ﬁbrosis and Escherichia coli in urinary
tract infections, bioﬁlms provide an important reservoir of
cells that can repopulate colonized sites upon removal of
drug treatment (Singh et al., 2000; Anderson et al., 2004).
As a correlation between bioﬁlm formation and bacterial
persistence has been proposed (Costerton et al., 1999;
Balaban et al., 2004; Roberts and Stewart, 2005), the
question arises as to whether M. tuberculosis can form
drug-tolerant bioﬁlms. If so, it raises the possibility of M.
tuberculosis bioﬁlm formation as a potential new target for
drugs that facilitate the use of current anti-tuberculosis
antibiotics administered in ultra-short regimens. In a
surfactant-free liquid medium culture, M. tuberculosis
can form organized pellicle-like structures on the air–
media interface (Darzins and Fahr, 1956), although the
growth characteristics and persistence of the pathogen in
these multicellular communities have not been closely
scrutinized.
Cellular and molecular studies on bioﬁlms of several
mycobacterial species have been performed (Schulze-
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Lappin-Scott, 1998; Marsollier et al., 2005; Hall-Stoodley
et al., 2006). Mycobacterium smegmatis forms bioﬁlms
both on PVC surfaces and on liquid–air interfaces, and
exhibits sliding motility on agar surface; the genetic
requirements for bioﬁlm formation and sliding motility are
similar (Recht and Kolter, 2001; Ojha et al., 2005; Ojha
and Hatfull, 2007). M. smegmatis bioﬁlm formation
requires a low level of supplemental iron that is acquired
by the exochelin uptake system (Ojha and Hatfull, 2007)
and is genetically distinct from planktonic growth (Recht
and Kolter, 2001; Ojha et al., 2005). Unlike most other
bioﬁlm-forming bacteria, M. smegmatis bioﬁlms contain
a lipid-rich extracellular matrix and the FAS-II system
responsible for the synthesis of mycolic acids is impli-
cated in this process (Ojha et al., 2005). In particular,
mutations in both inhA and kasB give rise to bioﬁlm
defects, and GroEL1 – a dedicated chaperone for bioﬁlm
formation – speciﬁcally interacts with components of the
FAS-II system. Mycolic acid synthesis is therefore closely
associated with M. smegmatis bioﬁlm formation and this is
of particular note as the front-line anti-tuberculosis drug
isoniazid acts on the essential InhA enzyme in mycolate
synthesis (Vilcheze et al., 2006).
Here, we investigate the conditions that support growth
of M. tuberculosis bioﬁlms and demonstrate that bioﬁlm
formation is genetically and physiologically distinct from
planktonic growth of M. tuberculosis. These bioﬁlms are
unusual in that the tubercle bacilli are embedded in a
lipid-rich extracellular matrix containing free methoxy
mycolic acids. Moreover, we show that M. tuberculosis
bioﬁlms are drug-tolerant and harbour persistent cells
that survive high concentrations of anti-tuberculosis
antibiotics.
Results and discussion
Growth of M. tuberculosis bioﬁlms
Bioﬁlm growth of non-tuberculosis mycobacteria is depen-
dent on growth conditions and medium. M. tuberculosis
does not grow in the modiﬁed M63 medium that supports
formation of M. smegmatis bioﬁlms at liquid–air interfaces
(Recht et al., 2000; Branda et al., 2005; A.K. Ojha and
G.F. Hatfull, unpubl. obs.) and, in an established medium,
such as Sauton’s, we found that both M. tuberculosis and
Mycobacterium bovis BCG form a thin ﬁlm in a Petri dish
without the thick textured reticulation that is typical of
mature bioﬁlms of M. smegmatis and other mycobacteria
(Fig. 1A). However, serendipitously we observed that
when using the same Sauton’s medium, the sealing of the
dishes with paraﬁlm supports growth of lush mature bio-
ﬁlms by both M. bovis and M. tuberculosis (Fig. 1A) after
5 weeks of incubation, which are visually indistinguishable
from those of M. smegmatis.
We propose that there are two aspects of these
paraﬁlm-covered dishes that are important for bioﬁlm
growth and maturation. First, as paraﬁlm is likely to restrict
the loss of gases and volatile substances by diffusion, we
suggest that these volatile agents may either mediate
signalling events or satisfy speciﬁc metabolic require-
ments needed for bioﬁlm maturation. Second, because
bioﬁlm maturation of other mycobacteria requires contin-
ued bacterial growth, it seems likely that the property of
paraﬁlm to permit diffusion of oxygen is an important
parameter. We note that this underscores a signiﬁcant
difference with models of mycobacterial dormancy which
require a micro-anaerobic environment (Wayne and
Sohaskey, 2001).
We have reproduced M. tuberculosis bioﬁlm growth
using polystyrene bottles, which provide more robust and
reproducible conditions. In this format, the medium occu-
pies approximately 10% of the bottle volume and is inocu-
lated by adding cells from a saturated planktonic culture at
a 1:100 dilution. If the bottle is tight-capped, then after
3 weeks of incubation, attachment of M. tuberculosis cells
to the sides of the polystyrene bottles and some matura-
tion is observed, but there is little change to the bioﬁlm
appearance over the subsequent 2 weeks of incubation
(Fig. 1B). In contrast, if the bottle caps are kept loosely
associated, then bioﬁlm formation is noticeably retarded,
and little attachment or maturation is observed after
3 weeks’ incubation, and is only apparent after 5 weeks of
incubation (Fig. 1B). We ﬁnd that optimal bioﬁlm formation
is observed by maintaining the bottle tightly capped for
3 weeks, and then loosening the caps for the last 2 weeks
(Fig. 1B). This is a simple and robust bioﬁlm model that –
even though the extent and timing of bioﬁlm development
may vary with bottles and caps – enables analysis of gas
accumulation under these conditions.
To identify putative gases and volatile substances that
are required for bioﬁlm formation, we analysed the gases
by gas chromatography/mass spectrometry (GC/MS),
comparing those in the head-space of a tight-capped
bottle used to grow M. tuberculosis bioﬁlms with those in
a loose-capped bottle (Fig. 1C). This analysis showed
accumulation of CO2 (44 amu) and lower abundance of
oxygen (32 amu) in the tight-capped bottle (Fig. 1C).
Other volatile substances may be present, but at concen-
trations too low for detection by GC/MS. A critical role for
CO2 seems implausible as we would expect it to diffuse
through a paraﬁlm cover (Fig. 1A).
Role of carbon dioxide in M. tuberculosis
bioﬁlm formation
Phenotypic analysis of mutants attenuated in the ability to
produce CO2 suggests that CO2 availability plays a role
in M. tuberculosis bioﬁlm formation. For example, a M.
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2-oxoglutarate dehydrogenase (encoded by Rv2454c and
Rv2455c; A. D. Baughn and W. R. Jacobs, unpubl. data)
and requires exogenous CO2 for growth on solid medium
is defective in bioﬁlm formation (Fig. 2A). Bioﬁlm forma-
tion by this strain was partially restored either by preclud-
ing gas exchange (tightening the cap of the culture
vessel) during the ﬁrst 3 weeks of incubation, or by
complementing the genetic defect by integration of the
wild-type Rv2454c-Rv2455c locus (Fig. 2A). We recog-
nize that this mutant is likely to have substantial alter-
ations in its overall carbon metabolism and, owing to the
presence of other similarly prominent metabolic sources
of CO2, namely isocitrate dehydrogenase and pyruvate
dehydrogenase, it is possible that CO2 accessibility is not
the sole factor necessary to promote M. tuberculosis
bioﬁlms. Yet, it is important to note that bioﬁlm formation of
the wild-type strain was stimulated by supplementation
with 5% CO2, although to a far lesser degree than sealing
of the culture vessel (Fig. 2B). Overall, these data suggest
that changes in the composition of the gaseous space
other than CO2 accumulation – such as decreasing
oxygen tension or increasing concentration of organic
volatile molecules – stimulate bioﬁlm development. We
have not been able to identify these by GC/MS and the
nature of the stimulant remains elusive.
Fig. 1. Growth of M. tuberculosis bioﬁlms.
A. M. bovis BCG or M. tuberculosis H37Rv was cultured in a Petri dish containing Sauton’s medium for 5 weeks with either a standard
loose-ﬁtting lid or with a sealed paraﬁlm covering.
B. Bottle assay for the growth of M. tuberculosis mc
27000 bioﬁlms. Bottle caps were kept either loose or tight for 5 weeks, or tight for the ﬁrst
3 weeks and loosened for the last 2 weeks, as indicated.
C. Gases present in either loosely capped or tightly capped bottles (as indicated) were examined by GC/MS. CO2 (44 amu) accumulates in
the tightly capped bottles.
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bioﬁlm maturation
Iron plays a central role in bioﬁlm formation (Banin et al.,
2005; Ojha and Hatfull, 2007) and we therefore examined
the iron dependence of M. tuberculosis bioﬁlms. Reducing
the normal amount of iron (to 2 mM) has no effect on
planktonic growth (Fig. S1) but severely retards bioﬁlm
growth (Fig. 2C). The effect is most apparent on the matu-
ration stages, and bacteria remain competent to attach to
the sides of the polystyrene bottles (Fig. 2C). The require-
ment of iron speciﬁcally for late bioﬁlm development rather
than attachment is similar to that reported for M. smegma-
tis, although we note that 2 mM iron is sufficient to support
full M. smegmatis bioﬁlm growth (Ojha and Hatfull, 2007).
Removal of the zinc supplement also interrupts M. tuber-
culosis bioﬁlm development (Fig. 2C) without affecting
planktonic growth (Fig. S1); interestingly, both iron and
zinc are important metal cofactors for enzymes involved in
CO2 generation and capture as well as synthesis of
mycolic acids. We note, for example, that carbonic anhy-
drase requires zinc for generating carbonate from CO2,
which is utilized by carboxybiotin-dependent acetyl CoA
carboxylases to make the malonyl-CoA and methylmalo-
nyl CoAprecursors for mycolic acid biosynthesis; whereas
FeS cluster proteins are required for synthesis of the biotin
cofactor.
Mycobacterium tuberculosis bioﬁlm growth is genetically
distinct from planktonic growth
To determine if bioﬁlm formation can be genetically differ-
entiated from planktonic growth, we isolated mutants from
a transposon insertion library of M. tuberculosis that have
reduced bioﬁlm growth (D. Sambandan and W. R. Jacobs
Jr, unpublished); one such mutant, mc27025, is strongly
defective (Fig. 2D), while growing normally in planktonic
culture (Fig. S1). The bioﬁlm defect is severe and, even
under optimal conditions, there is a nearly complete loss
of liquid surface growth, although there is still visible
attachment to the surfaces of the polystyrene bottles. The
transposon insertion maps to gene Rv1013 encoding a
putative acyl-CoA synthase and, although the genes and
its product are not well-characterized, it is reported to be
upregulated about twofold after 24 h starvation (Betts
et al., 2002); complementation with Rv1013 restores the
bioﬁlm phenotype (Fig. 2D). A second mutant – defective
Fig. 2. Environmental and genetic
requirements for M. tuberculosis bioﬁlms.
A. M. tuberculosis mc
24640, a mutant deleted
for genes encoding 2-oxoglutarate
dehydrogenase, requires CO2 for colony
formation on solid media and is defective in
bioﬁlm formation. Tightly capping the bottle for
the ﬁrst 3 weeks or complementing with
genes Rv2454c-Rv2455c (mc
24640/comp)
partially restores bioﬁlm formation; all cultures
were grown for 5 weeks.
B. Exogenous CO2 (5%) is not sufficient to
support full growth of M. tuberculosis bioﬁlms.
Bioﬁlms were grown in air or air
supplemented with 5% CO2 as shown.
C. Low iron (2 mM) and low zinc (none added)
inhibit bioﬁlm development with no effect on
planktonic growth (see Fig. S1).
D. M. tuberculosis strain mc
27025 defective in
gene Rv1013 is strongly defective in bioﬁlm
formation, and complemented by plasmid
pRv1013comp that contains the Rv1013
gene.
M.tuberculosis biofilms 167
© 2008 The Authors
Journal compilation © 2008 Blackwell Publishing Ltd, Molecular Microbiology, 69, 164–174in helY – shows a similar bioﬁlm defective phenotype
(data not shown). Clearly, bioﬁlm formation is a genetically
distinct state from planktonic growth or growth on solid
agar medium.
Mycobacterium tuberculosis bioﬁlms contain abundant
extractable free mycolic acids
Mycobacterium tuberculosis bioﬁlms are unusual in that
they contain novel lipids which are most likely deriva-
tives of mycolic acids (Ojha et al., 2005). Elevated level
of these lipids is closely associated with the late stages
of bioﬁlm maturation and a DgroEL1 mutant defective in
maturation fails to make these lipids (Ojha et al., 2005).
We therefore examined whether M. tuberculosis bioﬁlms
contain lipids that are not present in planktonic cultures.
Initially, we extracted both apolar and polar lipids from
planktonic and bioﬁlm cultures and compared them
by two-dimensional thin-layer chromatography (TLC)
as described previously (Dobson et al., 1985) (Fig. 3).
Overall, the lipid proﬁles for the two samples are very
similar, with two notable exceptions. First, triacylglycer-
ide (TG) is present in planktonically grown cells as
expected, but is present at a reduced level in the bioﬁlm
sample (Fig. 3A); presumably, TG is being used as an
intracellular carbon source in bioﬁlm growth, as has
been shown for starvation conditions (Deb et al., 2006).
Interestingly, extraction of apolar lipids and analysis by
TLC with solvent C (see Experimental procedures) show
the presence of a fatty acid (labelled Spot 1 in Fig. 3)
that is much more abundant in the bioﬁlm culture than in
planktonic cells.
Separation of Spot 1 by TLC and quantiﬁcation shows
that it is present in about ﬁvefold greater abundance in
bioﬁlms than in planktonically grown cells (Table S1).
Furthermore, the abundance of Spot 1 is reduced in
mc27025 mutant bioﬁlms grown under the same condi-
tions as the parental strain (Fig. 4A), indicating that
accumulation of spot 1 closely correlates with formation
of mature bioﬁlms structures. We further tested whether
Spot 1 is anchored to the mycobacterial cells within a
bioﬁlm, in which case a strong chemical hydrolysis
would be required to isolate it, or if it is extracellular and
can be readily extracted by a mild detergent treatment.
As shown in Fig. 4B, a substantial proportion of the Spot
1 material is readily extracted with Tween-80, consistent
with it being extracellular and presumably a component
of the extracellular matrix. To eliminate the possibility
that Spot 1 is also present in planktonically grown cells
but lost from the sample as a result of solubilization with
detergent, we analysed the supernatant of a planktonic
culture, but found that Spot 1 is absent (Fig. 4B). Spot 1
is thus speciﬁcally made by M. tuberculosis growing in
bioﬁlms.
Chemical analysis of Spot 1 shows that it corresponds
to free mycolic acids. First, we characterized the Spot 1
lipid by 1H-NMR, which shows speciﬁc signals indicative
of the presence of functional groups of mycolic acids
(Fig. 4C). In addition to the protons adjacent to the car-
boxyl group that are ubiquitously observed in mycolic
acids (Fig. 4C, Ha and Hb), cis-cyclopropyl (Fig. 4C, He,
Hf and Hg) and a-methyl methoxy groups (Fig. 4C, Hc,
Hd) are readily identiﬁed on the 1H-NMR spectrum and
conﬁrmed by 1H-13C HSQC NMR experiments (data not
shown), strongly suggesting the presence of methoxy
mycolates as major components, and probably a myco-
lates. In addition, minor signals assigned to keto groups
were observed in small amounts, establishing the pres-
ence of keto mycolates as minor compounds (about
10%). However, no signals indicative of cis-o rtrans-
Fig. 3. Lipid analysis of planktonically grown cells and bioﬁlms of
M. tuberculosis. Total apolar and polar lipids from planktonic and
bioﬁlm cultures of M. tuberculosis mc
27000 resolved on 2D-TLC are
solvent systems as described in the Experimental procedures
(solvent A, Sol. A; solvent C, Sol. C; solvent D, Sol. D). Samples
were labelled with
14C-acetate and equal amounts of total
radioactivity were examined. The lipids are annotated as previously
described (Besra, 1998): A–C, phthiocerol dimycoserosate family;
MK, menaquinone; D and E, apolar mycolipenates of trehalose; F,
free fatty acid; CF, cord factor; DAT, 2,3,-di-O-acyltrehaloses; SL,
sulphatides. Spot 1 which is induced in bioﬁlms is also marked.
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of a1 and a2 mycolates. Most informative are the 1H-NMR
chemical shifts of the -CHa- and -CHb- signals that are
noticeably de-shielded from 3.64 to 3.70 p.p.m. and from
2.43 to 2.46 p.p.m., respectively, compared with their
equivalents when the carboxyl group is methyl-esteriﬁed
(Watanabe et al., 2001), which suggests that the car-
boxyl group is free. Accordingly, 1H-13C HMBC experi-
Fig. 4. M. tuberculosis bioﬁlms contain free mycolic acids.
A. 1D-TLC of apolar lipids extracted from either M. tuberculosis mc
27000 cells or the mc
27025 mutant growing either planktonically or as
bioﬁlms resolved in solvent system C. Samples were labelled with
14C-acetate and equal amounts of total radioactivity were examined.
B. Tween-80 solubilization of bioﬁlm lipids. Bioﬁlm samples were Tween-80 extracted and the Tween-soluble and Tween-insoluble fractions
separated by TLC as above. The Tween-containing supernatant from planktonically grown cells was analysed similarly.
C.
1H-NMR spectrum of Spot 1.
1H signals of protons associated with functional groups were assigned using known chemical shifts (Watanabe
et al., 1999; X. Trivelli and Y. Guerardel, unpubl. obs.) and labelled (a to h) according to their relative positions. A slight de-shielding of Ha
(Dd + 0.06 p.p.m.) proton from 3.64 to 3.70 p.p.m. and Hb (Dd + 0.03 p.p.m.) proton from 2.43 to 2.46 p.p.m. compared with their equivalent
protons associated to a methyl-esteriﬁed carboxyl group is in agreement with the occurrence of a free mycolate.
D. MALDI-TOF-MS analysis of native (top panel), -CH3 (middle panel) and -CD3 (bottom panel) esteriﬁed Spot 1. Signals correspond to
[M + Na]
+ adducts of a family of methoxy mycolates.
E. Spot 1 (lane 1) was methyl-esteriﬁed (lane 2) and compared with methyl-esteriﬁed mycolic acids puriﬁed from Mtb cell wall (lane 3), by
resolution on a TLC plate developed in petroleum ether : acetone (95:5) and visualized as in Fig. 4A. a, m and k indicate the alpha, methoxy
and keto mycolic acids respectively.
M.tuberculosis biofilms 169
© 2008 The Authors
Journal compilation © 2008 Blackwell Publishing Ltd, Molecular Microbiology, 69, 164–174ment of Spot 1 (data not shown) did not show any
correlation between the carbon of the carboxyl group and
a proton of a potential carrier molecule through a 3JH-C.
Furthermore, although very close, the NMR parameters
of Hb also slightly differ from those of the -CH2-COOH
group of a free fatty acid (2.34 p.p.m.) because of the
de-shielding effect of the hydroxyl group in the beta posi-
tion of mycolic acids. This demonstrates that signals
associated with free carboxyl groups do not originate
from a contamination of free linear fatty acids in Spot 1.
These NMR data strongly suggest that the carboxyl
group of the mycolic acid is not engaged in linkage with
the C5 carbon of an arabinosyl residue or the C6 carbon
of a glucose residue – as observed in mAGP or in TDM
respectively – but is free.
The MALDI-TOF analysis of Spot 1 (Fig. 4D) shows
several major signals between m/z 1247 and 1331 with
14 mu increments ﬁtting with [M + Na]+ adducts either of
C82-C86 methyl-esteriﬁed methoxy-mycolic acids (Fujita
et al., 2005) or, in accordance with the NMR data, of a
family of C83-C87 free methoxy mycolates. In agreement
with this hypothesis, esteriﬁcation of Spot 1 with methyl
groups (-CH3) in aqueous strong alkali solution led to a
mass increment of 14 mu of all the signals, demonstrating
thepresenceofamethylablefunction,presumablythefree
carboxylic group, on the molecule. Values of methylated
compounds from m/z 1261–1345 ﬁt with those of C83-C87
methyl-esteriﬁed methoxy mycolates, as previously
described (Fujita et al., 2005). It is noteworthy that the
respective intensities of each signal before and after
methylation are almost identical (Fig. 4D), strongly sug-
gesting that both families of compounds are indeed
related. In addition, esteriﬁcation of Spot 1 with deutero-
methyl (-CD3) group incremented all signals by 17 mu,
which unambiguously demonstrated that the 14 mu incre-
ment was the result of the addition of a single methyl group
to the mycolic acid. Finally, 1H-NMR analysis of the methy-
lated product shows an almost identical spectrum to that of
the native molecule, only differing by the chemical shifts of
the -CHa- and -CHb- groups that shift back to their typical
values for methyl-esteriﬁed mycolic acids, demonstrating
that methylation occurred on the free carboxyl group. This
was further conﬁrmed by 1H-13C HMBC analysis of methy-
lated Spot 1 (data not shown) that showed a clear 3JH-C
correlation between the carbon of the carboxyl group and
the proton of the methyl group. TLC analysis of methyl-
esteriﬁed Spot 1 also conﬁrmed the presence of methoxy
mycolates with lesser amounts of both a and keto myco-
lates (Fig. 4E). Thus taken together, NMR, MS and TLC
analyses of native and methyl-esteriﬁed Spot 1 unambigu-
ously conﬁrm that it is composed of free mycolic acids, an
observation of some interest as we are not aware of any
other condition in which free mycolic acids are abundant
components of M. tuberculosis cultures.
Re-examination of the bioﬁlm-associated fatty acids of
M. smegmatis reported previously (Ojha et al., 2005) sug-
gests that these are also free mycolic acids (data not
shown). Apolar lipids with similar properties to those in M.
tuberculosis can be extracted without hydrolysis and are
at reduced levels in the DgroEL1 mutant (data not shown).
Thus, the development of bioﬁlm-associated extracellular
matrices composed of free mycolic acids is not unique to
M. tuberculosis, and it seems more likely that these are
common features of mycobacterial bioﬁlms. Furthermore,
the production of these M. smegmatis lipids does not
appear to be via de novo synthesis (Ojha et al., 2005), but
rather a GroEL1-mediated switch in the action of the
FAS-II system. Because the mycolates are usually
covalently attached to the cell surface, it is plausible that
the free mycolic acids primarily are generated by cleav-
age of the ester linkages anchoring them to arabinogalac-
tan, although a putative esterase that could be
responsible for this has yet to be identiﬁed. This suggests
the possibility that mycolic acids play two separate but
important roles in mycobacterial physiology: conferring
cohesion and structure to bioﬁlm communities of cells,
and only being cell-associated when mycobacterial cells
are free to migrate from one community to another. We
also note that while a groEL1 mutant of M. tuberculosis
exhibits no obvious bioﬁlm phenotype under the standard
conditions for bioﬁlm growth described here (A.K. Ojha
and G.F. Hatfull, unpubl. obs.), M. tuberculosis groEL1 is
required for granulomatous inﬂammation in both mice and
guinea pigs (Hu et al., 2008).
Mycobacterium tuberculosis bioﬁlms contain highly
drug-tolerant persister cells
Bacterial bioﬁlms typically have a high proportion of cells
that are non-responsive to antimicrobials, and these likely
correspond to persisters that arise as a result of pheno-
typic variation in a subpopulation of heterogeneous bacilli
and are seen in a variety of microbial species (Spoering
and Lewis, 2001; Dhar and McKinney, 2007; Lewis,
2007). We therefore tested whether M. tuberculosis bio-
ﬁlms also display phenotypic variation in response to anti-
biotics (Fig. 5). In planktonic growth, incubation with either
isoniazid or rifampicin leads to cell death and the rate of
killing is linear over a 5 day period. In contrast, M. tuber-
culosis bioﬁlms have a high proportion of cells (~10%) that
survive isoniazid treatment, even at concentrations
(10 mgm l -1) greatly above the minimal inhibitory concen-
tration (MIC) (~0.1 mgm l -1). As isoniazid fails to kill non-
growing cells, this may simply mean that 10% of the cells
are not in an active growing state, although we note that
the mc27025 mutant is nearly 10-fold more sensitive than
its parent strain when grown under these conditions
(Fig. 5A).
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to high rifampicin exposure over a 3 day period with a
> 1000-fold reduction in viability (Fig. 5B); however,
further exposure causes no reduction in viability, indicat-
ing a substantial subpopulation of cells surviving this
treatment. At lower concentrations of rifampicin
(10 mgm l -1) – still substantially above the MIC
(~1 mgm l -1) – an even greater proportion of drug-tolerant
persisters was observed (~8%; Fig. 5C) following 7 days
of exposure. Reducing the INH concentration to 1 mgm l -1
somewhat reduced the proportion of drug-tolerant bioﬁlm
cells, but did exhibit a modest synergistic effect when
used in combination with rifampicin (Fig. 5C).
This biphasic killing curve in response to rifampicin
treatment (Fig. 5A and B) is characteristic of cultures that
contain a substantial proportion of persisters, cells that
are not killed by the antibiotics but remain genetically
sensitive (Dhar and McKinney, 2007); in patients, M.
tuberculosis is killed rapidly over the ﬁrst 2 days of drug
treatment, but more slowly thereafter (Jindani et al.,
2003). We have analysed the colonies recovered after
5 days of rifampicin treatment, and all tested remain fully
antibiotic-sensitive. M. tuberculosis mc27025 does not
contain these persisters (Fig. 5B), demonstrating that
drug tolerance is bioﬁlm-dependent.
Conclusions
In this study, we have shown that M. tuberculosis forms
pellicular bioﬁlms that are distinct from planktonic growth.
We have demonstrated that the M. tuberculosis requires
a speciﬁc environment and genetic programme to
form organized bioﬁlm communities which harbour drug-
tolerant cells within a structure rich in free mycolic acids.
Although the question as to whether M. tuberculosis forms
bioﬁlms during infectious growth has received little atten-
tion, within the primary granulomas in guinea pig lungs, an
acellular rim has been observed adjacent to the edge of
the mineralizing central necrosis containing drug-tolerant
bacteria in microcolonies with features reminiscent of bio-
ﬁlms (Lenaerts et al., 2007). Taken together with our dem-
onstration that M. tuberculosis forms bioﬁlms as a deﬁned
and distinct physiological state harbouring drug-tolerant
persisters, we propose that bioﬁlm development repre-
sents an excellent drug target. Identiﬁcation of drugs that
inhibit bioﬁlm formation could enable the dramatic short-
ening of tuberculosis treatments using standard antibiot-
ics, with substantial potential impact on global health
and reduction of antibiotic resistance associated with
non-compliance.
Experimental procedures
Bacterial strains, media and growth conditions
Mycobacterium tuberculosis mc
27000 is an unmarked
version of mc
26030 (Sambandamurthy et al., 2006) and
the hyg sacB cassette was removed by transduction with
Fig. 5. M. tuberculosis bioﬁlms are drug-tolerant. M. tuberculosis
mc
27000 or the bioﬁlm-defective mc
27025 mutant were grown
planktonically or as bioﬁlms and treated with either isoniazid (A) or
rifampicin (B); the percentages of viable cells remaining after
different times of drug treatment are shown. (C) Percentage of
surviving cells following 7 day treatment of M. tuberculosis bioﬁlms
with antibiotics at different concentrations.
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sucrose-resistant and hygromycin-sensitive isolates.
mc
27000 fails to kill SCID mice following intravenous chal-
lenge and is ultimately cleared and has been approved for
use in Biosafety Level 2 containment by the Institutional
Biosafety Committees of the Albert Einstein College of Medi-
cine and University of Pittsburgh. Unless otherwise stated, M.
bovis BCG (Pasteur) and M. tuberculosis mc
27000 were
grown planktonically in 7H9OADC with 0.05% Tween-80 in
5% CO2 and mc
27000 was supplemented with 100 mgm l
-1 of
pantothenic acid. Antibiotics hygromycin (75 mgm l
-1) and
kanamycin (25 mgm l
-1) were added as appropriate.
Bioﬁlm growth
Bioﬁlms of M. bovis BCG and M. tuberculosis (mc
27000) were
grown in polystyrene Petri dishes by inoculating 10 ml of
Sauton’s medium (without Tween-80) with 100 ml of a satu-
rated planktonic culture and incubating without shaking at
37°C for 5 weeks in humidiﬁed conditions. The dishes were
either unwrapped or wrapped with paraﬁlm during incubation.





27025) were also grown in 250 ml polysty-
rene bottles by inoculating 25 ml of Sauton’s media with
250 ml of a saturated planktonic culture and incubating
without shaking at 37°C for 5 weeks. Bottles were incubated
either loose- or tight-capped in air or with 5% CO2.
Isolation of M. tuberculosis bioﬁlm-defective mutants
A TnHimar transposon library of M. tuberculosis,m c
27000
(Bardarov et al., 1997), was screened for mutants defective in
theformationofbioﬁlmsin96-wellplates.Singlecolonieswere
inoculated into Sauton’s media without Tween-80 and incu-
bated at 37°C for 5 weeks (D. Sambandan et. al., in prepara-
tion). Transposon insertion sites were determined by junction
cloning and DNAsequencing. Construction of M. tuberculosis
mc
24640wasconstructedbyreplacingRv2454candRv2455c
for 2-oxoglutarate dehydrogenase (nucleotides 2753746–
2756555 corresponding to the published H37Rv genome
sequence, Cole et al., 1998) of mc
27000 with a hygromycin-
resistance cassette (Bardarov et al., 2002); mc
24640-comp
was constructed by transformation with a pYUB1052 deri-
vative (Braunstein et al., 2000) containing the Rv2454c-
Rv2455c region (H37Rv nucleotides 2721932–2757635).
GC-MS analysis
Bioﬁlms of mc
27000 were grown in 24 ml of Sauton’s media in
236 ml screw-capped glass bottles (with hole caps and
septa) in either tightened or loosened-lid conditions. After
3 weeks of incubation, the lids of all the bottles were tight-
ened and the air from the overhead space withdrawn and
injected into a GC-MS instrument (Hewlett Packard) with
Agilent J and W column. The instrument was maintained at
20°C for the entire run time and the mass spectra of the GC
peaks were collected between 1 and 200 amu.
Drug tolerance assays
For the drug tolerance assay, bioﬁlms of M. tuberculosis
(mc
27000 and mc
27025) were grown in 12-well polystyrene
tissue culture plates, each well containing 6 ml of Sauton’s
media and inoculated with 60 ml of saturated planktonic
culture. The plates were paraﬁlm-wrapped and incubated at
37°C for 5 weeks. One set of cultures was harvested at time
t0 by collecting the biomass in 0.2% Tween-80, gentle agita-
tion at 4°C for 24 h with 1 mm glass beads and plated for cell
viability. From the remaining wells, one set was kept as
‘no-drug control’ and to the rest, either isoniazid (20 mgm l
-1)
or rifampicin (50 mgm l
-1) was injected through the bioﬁlm
into the media. Cells were harvested at various times with
0.2% Tween-80, washed twice with Sauton’s medium, re-
suspended in 6 ml of the same medium, gently agitated at
4°C for 24 h with 0.1% Tween and 1 mm glass beads, and
cell viabilities determined. Planktonic cultures of the mc
27000
and mc
27025 at 0.2 OD were exposed to the same drug
concentrations and viabilities determined.
Lipid extraction and analysis
Mycobacterium tuberculosis was grown planktonically to
OD 0.2 or in bioﬁlms for 5 weeks, labelled with 1.0 mCi ml
-1 of
14C acetate for 24 h prior, and harvested. Cells were
re-suspended in 5 ml of methanol: 0.3% NaCl (100:10),
mixed with 2.5 ml of petroleum ether for 30 min at room
temperature, and the upper petroleum ether layer containing
the apolar lipids separated by centrifugation. After solvent
evaporation, apolar lipids were dissolved in 0.5 ml of Dichlo-
romethane, and amounts equivalent to 50 000 counts of each
sample were analysed by silica two-dimensional TLC devel-
oped in solvent systems A (1st dimension – petroleum ether/
ethyl acetate 98:2 three times, 2nd dimension – petroleum
ether/acetone 98:2), C (1st dimension – chloroform/methanol
96:4, 2nd dimension – toulene/acetone 80:20) and D (1st
dimension – chloroform/methanol/water 100:14:0.8, 2nd
dimension – chloroform/acetone/methanol/water 50:60:2.5:3)
described previously (Dobson et al., 1985). Lipids equivalent
to 50 000 c.p.m. were loaded from each sample and visual-
ized by spraying 5% molybdophosphoric acid.
The polar lipids from the menthanol-saline bottom layer
were extracted following the same protocol and the lipids
were resolved on 2D-TLC using solvent system D.
Free and cell-associated lipids were separated by extrac-
tion of 5 week bioﬁlms in 15 ml of PBS containing 0.2%
Tween-80 and 1 mm glass beads for 24 h, followed by cen-
trifugation at 6000 r.p.m. for 15 min. Apolar lipids were
extracted from the supernatant and the cell pellet as
described above. For further analysis of Spot 1, the lipid was
scraped off a TLC plate, extracted thrice in diethyl ether and
dried.
Mass spectrometry
Mass spectrometry analyses of Spot 1 were done on a
Voyager Elite reﬂectron MALDI-TOF mass spectrometer (Per-
Septive Biosystems, Framingham, MA, USA), equipped with
a 337 nm UV laser. Samples were solubilized in 1 ml of
chloroform/methanol (2:1) of which 1 ml was mixed with 1 mlo f
2,5-dihydroxybenzoic acid matrix solution (10 mg ml
-1 dis-
solved in chloroform/methanol 2:1). Spot 1 was analysed in
nativeandesteriﬁedforms;driedsamplesweretreatedin1 ml
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esteriﬁed by adding 2 ml of chloroform, 1 ml of water and
150 ml of either ICH3 or ICD3 and sonicated for 1 h. Methyl-
esteriﬁed samples were extracted twice with chloroform/water
mixture and dried under a stream of nitrogen.
NMR analyses
Samples were dissolved into deuterated chloroform contain-
ing 0.03% of TMS for
1H and
13C referring and transferred into
Shigemi tubes matched for D2O. 0.1 ml of deuterium oxide
was added to avoid solvent evaporation during long acquisi-
tion (Wieruszeski et al., 2006). 1D proton, 2D-COSY,
2D-ROESY with 400 and 450 ms mixing time, 2D-
13C-HSQC
with multiplicity editing during selecting step and 2D-HMBC
experiments were recorded at 299K on a 800 MHz Avance II





2H and a broad-band probes
respectively.
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